Stay informed with the latest updates for the inheritable blood disorders community. Industry CSL Behring States Stimate Will Not Be Resupplied until 2022Oct 2, 2020 Industry Sanofi Publishes Updates to BIVV001 Trial Sep 17, 2020 Industry BioMarin’s New Clinical Study to Focus on Antibody Development to AAVsSep 9, 2020 Industry Mylan Initiates Voluntary…Sep 2, 2020 Industry FDA Recommends Additional Data for BioMarin’s Investigational Gene Therapy…Aug 19, 2020 Industry Novo Nordisk Announces Near Resumption of Concizumab TrialsAug 17, 2020 Industry Stimate Recall UpdateAug 7, 2020 Industry Genentech Presents New Hemlibra® Safety Data During Virtual ISTH Congress…Jul 14, 2020 Industry Spark Presents Gene Therapy Trial Updates at ISTH Virtual Congress Jul 13, 2020 Industry CSL Acquires Hemophilia B Gene Therapy Candidate from uniQureJun 25, 2020 Industry Sanofi and Sobi Make Additional Factor Donation to Aid ProgramJun 17, 2020 Industry BioMarin Releases Trial Updates in Lead Up to WFH Virtual SummitJun 3, 2020 COVID-19 Statement from Novo Nordisk on Rebinyn and COVID-19May 18, 2020 Industry Voluntary Recall Notice for BD PosiFlush™ SF Saline Flush SyringesApr 22, 2020 COVID-19 Genentech Notice on COVID-19, Hemlibra®, and Laboratory AssaysApr 16, 2020 Pagination First page Previous page … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Last page
